FreshRSS

🔒
❌ Acerca de FreshRSS
Hay nuevos artículos disponibles. Pincha para refrescar la página.
AnteayerTus fuentes RSS

Seeing is believing: Understanding the experiences and needs of marginalized communities living through successive disasters using photovoice

by Laura de la Roche, Carlos G. Fuentes, Ailiya Z. Jafry, Omolola E. Adepoju

Introduction

Reports indicate increasing prevalence rates of successive natural disasters, and the negative impact on existing infrastructures are well documented. However, factors impacting outcomes on both communities and individuals remain unclear. For historically underserved communities, the effects of disasters are exacerbated by pre-existing barriers that make efforts to recovery difficult. Thus, understanding the nuance of their circumstances and experience is crucial to helping build resilience in these communities and inform preparedness and response efforts.

Objective

Through this study, we sought to qualitatively understand the lived experience of historically underserved communities in the context of natural disasters to support the development and/or adoption of resources.

Methods

Photovoice was used to guide semi-structured interviews with participants recruited from three communities (Kashmere Gardens, Greater Third Ward, Greater Fifth Ward) in Houston, TX. Reflexive thematic analysis was employed to generate themes accurately depicting participant experiences. Reflexivity, persistent observation, and triangulation were employed to increase trustworthiness in analysis.

Results

Five key themes emerged from analysis: 1) Acute and long-term damage from natural disasters requires sustained recovery efforts; 2) Gaps and opportunities exist in city, state, and federal support mechanisms; 3) Strengthening and expanding support networks and community resources after extreme weather events is critical; 4) Need to address structural barriers to disaster preparedness and coping; and 5) Recognizing and mitigating the broad mental health impacts of natural disasters.

Conclusion

The lived experiences of individuals from historically underserved communities in Houston highlight a complex interaction of psychosocial, structural, and cultural factors that influence both community resilience and vulnerability. Understanding this interplay is crucial to informing policy efforts that prioritize resilience building in these communities. Implications from these findings are discussed.

Workforce management and patient outcomes in the intensive care unit during the COVID‐19 pandemic and beyond: a discursive paper

Abstract

Aims

To highlight the need for the development of effective and realistic workforce strategies for critical care nurses, in both a steady state and pandemic.

Background

In acute care settings, there is an inverse relationship between nurse staffing and iatrogenesis, including mortality. Despite this, there remains a lack of consensus on how to determine safe staffing levels. Intensive care units (ICU) provide highly specialised complex healthcare treatments. In developed countries, mortality rates in the ICU setting are high and significantly varied after adjustment for diagnosis. The variability has been attributed to systems, patient and provider issues including the workload of critical care nurses.

Design

Discursive paper.

Findings

Nursing workforce is the single most influential mediating variable on ICU patient outcomes. Numerous systematic reviews have been undertaken in an effort to quantify the effect of critical care nurses on mortality and morbidity, invariably leading to the conclusion that the association is similar to that reported in acute care studies. This is a consequence of methodological limitations, inconsistent operational definitions and variability in endpoint measures. We evaluated the impact inadequate measurement has had on capturing relevant critical care data, and we argue for the need to develop effective and realistic ICU workforce measures.

Conclusion

COVID-19 has placed an unprecedented demand on providing health care in the ICU. Mortality associated with ICU admission has been startling during the pandemic. While ICU systems have largely remained static, the context in which care is provided is profoundly dynamic and the role and impact of the critical care nurse needs to be measured accordingly. Often, nurses are passive recipients of unplanned and under-resourced changes to workload, and this has been brought into stark visibility with the current COVID-19 situation. Unless critical care nurses are engaged in systems management, achieving consistently optimal ICU patient outcomes will remain elusive.

Relevance to clinical practice

Objective measures commonly fail to capture the complexity of the critical care nurses’ role despite evidence to indicate that as workload increases so does risk of patient mortality, job stress and attrition. Critical care nurses must lead system change to develop and evaluate valid and reliable workforce measures.

Safety and immunogenicity of rVSV{Delta}G-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial

Por: Gokani · K. · Taylor · A. · Packham · A. · Musabyimana · J. P. · Shema · H. · Mutabaruka · A. · Roche · S. · Takwoingi · Y. · Umuhoza · C. · Nyombayire · J. · Muvunyi · C. · Green · C.
Introduction

Ebola virus disease remains a significant public health concern. For protection from Ebola virus, the main target populations are epidemiologically identified and often include healthcare workers and refugees. These target populations are also routinely offered vaccines for other vaccine-preventable diseases. However, concomitant use of rVSVG-ZEBOV-GP with other vaccines is not recommended, given the absence of data regarding its reactogenicity and antigen-specific immunogenicity profile when co-administered. The EbolaCov trial aims to inform whether rVSVG-ZEBOV-GP can be administered concurrent to a Pfizer–BioNTech COVID-19 booster dose without an unacceptable increase in reactogenicity and/or loss of humoral immunogenicity to Ebola vaccine antigen.

Methods and analysis

This is a single-centre, randomised, single-blinded, vaccine safety and immunogenicity study in healthy adults living in Rwanda. Seventy-two participants will be randomised in a 1:1 ratio to two study groups, the first receiving rVSVG-ZEBOV-GP with a placebo, the second group receiving rVSVG-ZEBOV-GP concurrently with a Pfizer–BioNTech COVID-19 booster dose. The primary outcome measures are quantitative serum anti-glycoprotein (GP) antibody responses, as measured by ELISA, 28 days after vaccination, and frequency and severity of adverse events in the 7 days following vaccination. Secondary outcome measures include day 28 and day 180 serum anti-GP and serum SARS-CoV-2 anti-spike protein-specific geometric mean antibody titres.

Ethics and dissemination

This trial was approved by the Rwanda National Ethics Committee (reference 442/2024) and the University of Birmingham (reference ERN_2661-Jun2024). All participants were required to provide written informed consent in accordance with good clinical practice. Dissemination of results will be through conference presentations and peer-reviewed publications.

Trial registration number

Pan African Clinical Trials Registry (PACTR202407764378004) and ClinicalTrials.gov (NCT06587503)

Nurses' Opinions About Clinical Nursing Research: A Cross‐Sectional Study

ABSTRACT

Aim

To examine nurses' opinions and assess their level of engagement in clinical research.

Design

An observational study employing a cross-sectional online survey from April to August 2024.

Methods

A convenience sample of registered nurses in a metropolitan health service in Victoria, Australia completed a self-report survey from April to August 2024. The survey consisted of fixed-response questions (5-point Likert scale) that measured nurses' opinions about clinical research and level of research involvement. Data were analysed using descriptive and univariate statistics, and content for two free-text open-ended questions.

Results

There were 186 participants who reported positive opinions towards the role of clinical nursing research in improving patient outcomes and quality of care. Lower ratings were observed for items concerning confidence in understanding and conducting research, enjoyment of reading research articles and access to resources necessary for participation in research. Few participants had previous experience in study design, data analysis and manuscript preparation and publication. Nurses with higher academic qualifications (e.g., Master's, PhD), and those employed in senior roles, had more positive opinions about clinical nursing research and were more actively engaged in it. Content analysis revealed five themes: (1) Accessibility and awareness of research opportunities, (2) Support and resources, (3) Time constraints and workload, (4) Professional development and (5) Integration of research into clinical practice.

Conclusions

Whilst nurses perceive the importance of research, the findings underscore the need for targeted strategies to build their confidence and capacity to engage in clinical nursing research.

Implications for the Profession

Nurses face significant barriers to active participation in research. Consideration is needed regarding how nurses are prepared for and adequately resourced to increase their involvement in clinical nursing research.

Impact

This study addresses the gap in evidence regarding nurses' opinions and level of engagement in clinical nursing research. Research leaders need to develop and test interventions to increase nurses' involvement in research.

Patient or Public Contribution

This study did not include patient or public involvement in its design, conduct or reporting.

Behaviour change interventions addressing patient antibiotic treatment-seeking behaviour for respiratory tract infections in primary and community care settings: a scoping review

Por: Maher · A. · Roche · K. · Morrissey · E. · Murphy · A. · Sheaf · G. · Ryan · C. · Molloy · G. J.
Objectives

This scoping review aimed to map studies on behaviour change interventions that address antibiotic treatment-seeking behaviour for respiratory tract infections in primary and community care settings.

Design

This review is based on the Joanna Briggs Institute guidelines for scoping reviews, guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews.

Data sources

A literature search in January 2024 and May 2024 was performed across Medline, Embase, CINAHL, PsycINFO, Web of Science Core Collection, Scopus, EThOS and Google Scholar was performed.

Eligibility criteria

Eligible studies described behaviour change interventions in primary and community care settings, published from 2000 onward across all countries.

Data extraction and synthesis

Descriptive data relating to study details and intervention functions were gathered and organised according to the Capability, Opportunity, Motivation and Behaviour change framework in a predeveloped data extraction sheet. Dual data extraction occurred, and inter-rater reliability results are reported (K=0.83).

Results

The scoping review identified 38 eligible studies, which consisted of randomised controlled trials (7/38), cluster randomised controlled trials (6/38), randomised experiments (5/38), cross-sectional studies (5/38), qualitative investigations (5/38) and quasi-experimental designs (4/38). Most interventions focused on educational resources (15/38), digital tools (7/38) and community campaigns (6/38), with fewer targeting decision-making processes (4/38) or psychological drivers of antibiotic-seeking behaviour (3/38). Only one study was conducted in low-income and middle-income countries, and only one separately assessed behaviour change as a measured outcome.

Conclusions

This scoping review highlights a wide range of research methodologies within the topic area. There was some limited evidence of intervention efficacy for antibiotic prescription rates, particularly interventions focused on enhancing knowledge and access to resources. However, more emphasis is needed on standardising outcome measures and evaluating long-term outcomes.

Implementation of a preoperative exercise programme in lung cancer resection: protocol for a mixed-methods study

Por: King · M. · Roche · N. · Harris · B. · Hibbert · M. · Don · G. · Dale · M. · King · G. G. · Wootton · S.
Introduction

Preoperative exercise training is recommended, when feasible, for people undergoing resection for lung cancer and has been shown to reduce the risk of postoperative pulmonary complications and improve preoperative exercise capacity. However, preoperative exercise training programmes are not commonly available in the Australian clinical practice setting due to a range of factors including resource and time restrictions. We aim to describe the protocol to evaluate the implementation of an existing preoperative exercise training programme in people undergoing lung cancer resection in an Australian setting.

Methods and analysis

This is an evaluation of a secondary objective of a study examining the effect of lung cancer resection on exercise capacity, lung function and symptoms of dyspnoea and quality of life. Participants will be prospectively recruited at the time of lung cancer diagnosis and planned surgical treatment through the lung cancer multidisciplinary team of a metropolitan hospital in Sydney, Australia. All participants will be offered the choice of participating in the preoperative exercise training programme which encompasses a hybrid gym and telerehabilitation programme of up to five sessions/week from baseline until surgical date. The programme will be evaluated using the Reach, Effectiveness, Adoption, Implementation, Maintenance Framework including both quantitative and qualitative measures which will be analysed using descriptive statistics and qualitative analysis coded inductively.

Ethics and dissemination

The study has received ethical approval through the Northern Sydney Local Health District reference 2023/ETH01643 and has been registered prospectively. Findings will be disseminated through peer-reviewed publication and scientific conference presentation.

Trial registration number

ACTRN12624000359538.

The Characteristics and Effectiveness of Oral Healthcare Education Interventions for Stroke Clinicians: A Scoping Review

ABSTRACT

Aims

To explore the characteristics of oral healthcare education interventions for stroke clinicians and the effectiveness of these interventions in improving the oral health knowledge, attitudes, confidence, and practice among acute stroke clinicians.

Design

Scoping review, guided by Arksey and O'Malley's (2005) framework.

Methods

Original full-text studies reporting educational oral healthcare interventions for stroke clinicians, including but not limited to nurses, were eligible for inclusion. Included studies were extracted and appraised using the Joanna Briggs Institute (JBI) Checklist aligned to the study methodology. Narrative synthesis was used to describe heterogeneous findings.

Data Sources

Key electronic bibliographic databases including CINAHL, Cochrane, MEDLINE (Ovid), ProQuest, Pubmed, and Scopus, in addition to grey literature, were searched for studies published between 1st January 2000 and 20th January 2024.

Results

Five studies conducted in acute inpatient settings were included: two randomised controlled trials, two mixed-methods studies, and one quality improvement project. Most (n = 4) studies developed complex interventions that included education and other components (products, referral pathways, assessment tools), and were delivered either face-to-face or as an online program. Most studies reported positive changes in oral health knowledge, attitudes, and confidence. There was limited measurement of the acceptability and feasibility of the interventions, with only one study reporting positive feedback from clinicians. There was no evidence to support changes in clinical practice following any of the included interventions.

Conclusion

Existing evidence indicates interventions for stroke clinicians have some potential for building stroke clinicians' capacity to provide adequate oral healthcare. There is however no evidence linking these interventions to optimised patient outcomes. There is a need for research focused on the implementation and dissemination of tailored oral health educational interventions incorporating clinically meaningful outcomes.

Implications for Profession/Patient Care

Existing oral healthcare educational interventions appear to have a positive effect on stroke clinicians' oral health knowledge, confidence, and attitudes. Educational interventions in oral healthcare are perceived to be acceptable and feasible; however, further research is needed to design and test the effect of new interventions.

Impact

Integrated oral healthcare is particularly important for stroke survivors who are at greater risk of preventable aspiration pneumonia. This scoping review highlights the characteristics of existing educational programs for stroke clinicians, their effectiveness, and gaps in existing evidence. Review findings substantiate the need for future research to enhance existing oral healthcare interventions, to translate knowledge acquired from training into clinical practice, and to capture appropriate measures of effect.

Reporting Method

The PRISMA-ScR Checklist.

Protocol Registration

This review was registered with the Open Science Framework registry (https://doi.org/10.17605/OSF.IO/4BWVF).

INFORM‐AF II—Phase 1 pilot randomised controlled trial evaluating the effect of an atrial fibrillation digital education programme: study protocol

Abstract

Aim

To evaluate the effect of a novel, co-designed, digital AF educational program, ‘INFORM-AF’, to reduce re-hospitalisation of people with AF.

The secondary aims are to examine the effect of the intervention on: (a) reducing cardiovascular-related hospitalisation, (b) increasing medication adherence, AF-related knowledge, and Atrial fibrillation (AF)-related quality of life and (c) determining the cost-effectiveness of the intervention.

Background

AF is an increasingly prevalent cardiac arrythmia that involves complex clinical management. Comprehensive education is essential for successful self-management of AF and is associated with positive health-related outcomes. There has been an increase in technology-based education for AF. However, its effects on hospitalisation, medication adherence and patient-reported outcomes are unclear.

Design

A prospective, randomised (1:1), open-label, blinded-endpoint, multicentre clinical trial.

Methods

Eligible participants are aged 18 years or above, diagnosed with AF, and own a smartphone. The study will be conducted at two metropolitan hospitals. In the intervention group, participants will receive the AF educational program delivered via Qstream®. In the control group, participants will receive the Stroke Foundation ‘Living with AF’ booklet. The primary outcome is re-hospitalisation within 12 months from an indexed presentation or hospital admission.

Conclusion

This clinical trial is part of a developing program of work that will examine mHealth educational-behavioural interventions on cardiovascular outcomes. Findings from this pilot study will inform the development of a digital educational framework for patients living with AF.

Implications for the Profession and/or Patient Care

There remain many gaps in providing high-quality patient education for patients with AF. This trial will test a new theory-driven, smartphone-based education program on important clinical outcomes, including rehospitalisation.

Impact

This study evaluates a novel, co-designed, digital AF educational program, ‘INFORM-AF’, to reduce the re-hospitalisation of people with AF. Study results are expected to be reported in 2025. Findings are expected to inform practice recommendations for AF patient education that may be included in future clinical practice guideline recommendations.

Reporting Method

SPIRIT Checklist.

Patient or Publication Contribution

JL is a consumer co-researcher on the project and provided critical input into intervention design, and feedback and input across the study duration.

Patients' experiences of cancer immunotherapy with immune checkpoint inhibitors: A systematic review and thematic synthesis

Abstract

Aim

To obtain a deeper understanding of peoples' experiences of cancer treatments with immune checkpoint inhibitors (ICIs).

Background

ICIs are transforming survival outcomes for many with certain advanced cancers. Given the possibility of unique immune-related adverse events (irAEs), understanding treatment experiences is crucial to identify support needs and provide safe and effective person-centred care.

Design

A systematic review of qualitative research and thematic synthesis. To report this review, the Preferred Reporting Items for Systematic Analysis and Meta Analysis (PRISMA) checklist and Enhancing Transparency in Reporting the Synthesis of Qualitative Research (ENTREQ) guidance have been used.

Data Sources

MEDLINE, EMBASE, PsycINFO, CINAHL and Web of Science databases were searched in January 2022 for eligible studies published in English from database inception.

Review Methods

Two reviewers independently screened records, identified papers for inclusion and appraised methodological quality using the Critical Appraisal Skills Programme checklist. Themes were developed using thematic synthesis.

Results

Eighteen papers were included and three analytical themes developed: immune checkpoint inhibitor treatment decision-making; the experience and impact of immune checkpoint inhibitor treatments; and appraising and responding to irAEs.

Conclusion

The synthesis renders visible individuals' unmet information, psychological and practical support needs. It identifies shortcomings in immune checkpoint inhibitor treatment decision-making processes and highlights the need for healthcare professionals to recognise and sensitively handle individuals' treatment expectations. Individuals' understandings of and responses to irAEs are also illustrated, and attention drawn to patients' concerns about healthcare professionals' checkpoint inhibitor and irAEs knowledge.

Implications for Patient Care

To sensitively manage treatment expectations and uncertainties, and optimise health outcomes, there are distinct points in treatment trajectories where care and support might require adapting and enhancing.

Impact

This review addresses people's experiences of immune checkpoint inhibitor treatments. The core findings reveal unmet information, psychological and practical support needs. Insights derived from this review will enhance individuals' experiences and outcomes and healthcare professionals' practice.

Patient or Public Contribution

No patient or public involvement.

❌